146 related articles for article (PubMed ID: 1851845)
21. Development of a series of phenyltetrazole leukotriene D4 (LTD4) receptor antagonists.
Harper RW; Herron DK; Bollinger NG; Sawyer JS; Baldwin RF; Roman CR; Rinkema LE; Fleisch JH
J Med Chem; 1992 Apr; 35(7):1191-200. PubMed ID: 1313876
[TBL] [Abstract][Full Text] [Related]
22. Leukotriene receptor antagonists. III. Pharmacological and chemical studies with LY137617, a leukotriene D4 and leukotriene E4 receptor antagonist.
Herron DK; Whitesitt CA; Mallet BE; Rinkema LE; Haisch KD; Fleisch JH
Drugs Exp Clin Res; 1988; 14(5):303-10. PubMed ID: 2851426
[TBL] [Abstract][Full Text] [Related]
23. Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571.
Jones TR; Zamboni R; Belley M; Champion E; Charette L; Ford-Hutchinson AW; Gauthier JY; Leger S; Lord A; Masson P
Can J Physiol Pharmacol; 1991 Dec; 69(12):1847-54. PubMed ID: 1666333
[TBL] [Abstract][Full Text] [Related]
24. BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes.
Tudhope SR; Cuthbert NJ; Abram TS; Jennings MA; Maxey RJ; Thompson AM; Norman P; Gardiner PJ
Eur J Pharmacol; 1994 Nov; 264(3):317-23. PubMed ID: 7698171
[TBL] [Abstract][Full Text] [Related]
25. Biochemical and pharmacological characterization of the binding of the selective peptide-leukotriene antagonist, 3H-ICI 198,615, to leukotriene D4 receptors in guinea-pig lung membranes.
Aharony D; Falcone RC; Yee YK; Hesp B; Giles RE; Krell RD
Ann N Y Acad Sci; 1988; 524():162-80. PubMed ID: 2837952
[No Abstract] [Full Text] [Related]
26. Optimization of the quinoline and substituted benzyl moieties of a series of phenyltetrazole leukotriene D4 receptor antagonists.
Sawyer JS; Baldwin RF; Rinkema LE; Roman CR; Fleisch JH
J Med Chem; 1992 Apr; 35(7):1200-9. PubMed ID: 1313877
[TBL] [Abstract][Full Text] [Related]
27. Evidence for two leukotriene receptor types in the guinea-pig isolated ileum.
Gardiner PJ; Abram TS; Cuthbert NJ
Eur J Pharmacol; 1990 Jul; 182(2):291-9. PubMed ID: 2168834
[TBL] [Abstract][Full Text] [Related]
28. N-[(arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene D4 antagonists of novel structure.
Musser JH; Kreft AF; Bender RH; Kubrak DM; Carlson RP; Chang J; Hand JM
J Med Chem; 1989 Jun; 32(6):1176-83. PubMed ID: 2498516
[TBL] [Abstract][Full Text] [Related]
29. (Piperidinylalkoxy)chromones: novel antihistamines with additional antagonistic activity against leukotriene D4.
Zhang MQ; Wada Y; Sato F; Timmerman H
J Med Chem; 1995 Jun; 38(13):2472-7. PubMed ID: 7608912
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and contractile activity of new pseudopeptido and thioaromatic analogues of leukotriene D4.
Niel N; Rechencq E; Muller A; Vidal JP; Escale R; Durand T; Girard JP; Rossi JC; Bonne C
Prostaglandins; 1992 Jan; 43(1):45-54. PubMed ID: 1312247
[TBL] [Abstract][Full Text] [Related]
31. Leukotriene D4 receptor-mediated synthesis and release of arachidonic acid metabolites in guinea pig lung: induction of thromboxane and prostacyclin biosynthesis by leukotriene D4.
Mong S; Wu HL; Clark MA; Gleason JG; Crooke ST
J Pharmacol Exp Ther; 1986 Oct; 239(1):63-70. PubMed ID: 3020235
[TBL] [Abstract][Full Text] [Related]
32. (Phenylmethoxy)phenyl derivatives of omega-oxo- and omega-tetrazolylalkanoic acids and related tetrazoles. Synthesis and evaluation as leukotriene D4 receptor antagonists.
Dillard RD; Hahn RA; McCullough D; Carr FP; Rinkema LE; Roman CR; Fleisch JH
J Med Chem; 1991 Sep; 34(9):2768-78. PubMed ID: 1654427
[TBL] [Abstract][Full Text] [Related]
33. Evidence for leukotriene D4 receptors in guinea pig left atria.
Falcone RC; Aharony D; Orzechowski RF
J Pharmacol Exp Ther; 1991 Jul; 258(1):199-206. PubMed ID: 1649293
[TBL] [Abstract][Full Text] [Related]
34. Conformationally restricted leukotriene receptor antagonists: [(octahydro-2-oxo-7-tetradecylidene-2H-1-benzopyran-8-yl)thio]ace tic acids.
Gieske TH; Sabol JS; Weintraub PM; Raddatz R; Cregge RJ
Pharmacology; 1990; 40(5):271-6. PubMed ID: 2177202
[TBL] [Abstract][Full Text] [Related]
35. Leukotriene D4 receptors are not negatively coupled to adenylyl cyclase in guinea-pig lung parenchyma.
Giembycz MA; Diamond J; Rodger IW
Br J Pharmacol; 1993 Mar; 108(3):824-32. PubMed ID: 8385538
[TBL] [Abstract][Full Text] [Related]
36. Specific binding of 3H-ICI 198,615, a potent LTD4 antagonist, to guinea pig cardiac ventricular membranes.
Falcone RC; Orzechowski RF; Aharony D
Prostaglandins; 1990 Mar; 39(3):241-58. PubMed ID: 2160091
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of binding sites for ICI 198,615 in human lung parenchyma.
Rovati GE; Giovanazzi S; Mezzetti M; Nicosia S
Biochem Pharmacol; 1992 Oct; 44(7):1411-5. PubMed ID: 1329767
[TBL] [Abstract][Full Text] [Related]
38. Kinetic and pharmacologic analysis of [3H]leukotriene E4 binding to receptors on guinea pig lung membranes: evidence for selective binding to a subset of leukotriene D4 receptors.
Aharony D; Catanese CA; Falcone RC
J Pharmacol Exp Ther; 1989 Feb; 248(2):581-8. PubMed ID: 2537402
[TBL] [Abstract][Full Text] [Related]
39. Biochemical and pharmacological characterization of ICI 198,615: a peptide leukotriene receptor antagonist.
Krell RD; Kusner EJ; Aharony D; Giles RE
Eur J Pharmacol; 1989 Jan; 159(1):73-81. PubMed ID: 2565238
[TBL] [Abstract][Full Text] [Related]
40. Strategies in the design of peptidoleukotriene antagonists.
von Sprecher A; Beck A; Gerspacher M; Sallmann A; Anderson GP; Subramanian N; Niederhauser U; Bray MA
J Lipid Mediat; 1993; 6(1-3):265-73. PubMed ID: 8395249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
